A randomized trial of the antiviral remdesivir for the treatment of COVID-19 is underway but its open label design and lack of a placebo control raises concerns for John Mandrola, MD
from WebMD Health https://www.webmd.com/lung/news/20200413/dear-gilead-please-add-a-placebo-arm-to-remdesivir-trial?src=RSS_PUBLIC
0 Comments:
Post a Comment